These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 19535912)

  • 1. Advances in dengue vaccine development.
    Raviprakash K; Defang G; Burgess T; Porter K
    Hum Vaccin; 2009 Aug; 5(8):520-8. PubMed ID: 19535912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of dengue DNA vaccines.
    Danko JR; Beckett CG; Porter KR
    Vaccine; 2011 Sep; 29(42):7261-6. PubMed ID: 21777640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dengue vaccine: an update on recombinant subunit strategies.
    Martin J; Hermida L
    Acta Virol; 2016 Mar; 60(1):3-14. PubMed ID: 26982462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A molecular evaluation of dengue virus pathogenesis and its latest vaccine strategies.
    Faheem M; Raheel U; Riaz MN; Kanwal N; Javed F; us Sahar Sadaf Zaidi N; Qadri I
    Mol Biol Rep; 2011 Aug; 38(6):3731-40. PubMed ID: 21107723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation in mice of the immunogenicity and protective efficacy of a tetravalent subunit vaccine candidate against dengue virus.
    Lazo L; Izquierdo A; Suzarte E; Gil L; Valdés I; Marcos E; Álvarez M; Romero Y; Guzmán MG; Guillén G; Hermida Cruz L
    Microbiol Immunol; 2014 Apr; 58(4):219-26. PubMed ID: 24689365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant vesicular stomatitis virus-based dengue-2 vaccine candidate induces humoral response and protects mice against lethal infection.
    Lauretti F; Chattopadhyay A; de Oliveira França RF; Castro-Jorge L; Rose J; Fonseca BA
    Hum Vaccin Immunother; 2016 Sep; 12(9):2327-33. PubMed ID: 27185081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The development of Dengue vaccines. Introduction.
    Coller BA; Barrett AD; Thomas SJ
    Vaccine; 2011 Sep; 29(42):7219-20. PubMed ID: 21708208
    [No Abstract]   [Full Text] [Related]  

  • 8. A West Nile virus CD4 T cell epitope improves the immunogenicity of dengue virus serotype 2 vaccines.
    Hughes HR; Crill WD; Davis BS; Chang GJ
    Virology; 2012 Mar; 424(2):129-37. PubMed ID: 22244913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tropical diseases. Dengue vaccine trial poses public health quandary.
    Normile D
    Science; 2014 Jul; 345(6195):367-8. PubMed ID: 25061184
    [No Abstract]   [Full Text] [Related]  

  • 10. The immunogenicity of tetravalent dengue DNA vaccine in mice pre-exposed to Japanese encephalitis or Dengue virus antigens.
    Prompetchara E; Ketloy C; Keelapang P; Sittisombut N; Ruxrungtham K
    Asian Pac J Allergy Immunol; 2015 Sep; 33(3):182-8. PubMed ID: 26342114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective human trials with dengue virus vaccines and the NS1 antigen production among vaccine recipients.
    Arya SC; Agarwal N
    Hum Vaccin; 2011 Dec; 7(12):1394. PubMed ID: 22108041
    [No Abstract]   [Full Text] [Related]  

  • 12. Vaccination models and optimal control strategies to dengue.
    Rodrigues HS; Monteiro MT; Torres DF
    Math Biosci; 2014 Jan; 247():1-12. PubMed ID: 24513243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current issues in dengue vaccination.
    Thomas SJ; Endy TP
    Curr Opin Infect Dis; 2013 Oct; 26(5):429-34. PubMed ID: 23963259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dengue vaccines: Are they safe for travelers?
    Halstead SB; Aguiar M
    Travel Med Infect Dis; 2016; 14(4):378-83. PubMed ID: 27343438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dengue vaccine candidates in development.
    Durbin AP; Whitehead SS
    Curr Top Microbiol Immunol; 2010; 338():129-43. PubMed ID: 19802583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Call to action for dengue vaccine failure.
    Mahalingam S; Herring BL; Halstead SB
    Emerg Infect Dis; 2013 Aug; 19(8):1335-7. PubMed ID: 23876389
    [No Abstract]   [Full Text] [Related]  

  • 17. Review of dengue virus and the development of a vaccine.
    Murrell S; Wu SC; Butler M
    Biotechnol Adv; 2011; 29(2):239-47. PubMed ID: 21146601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent progress in dengue vaccine development.
    Wei J; Chen H; An J
    Virol Sin; 2014 Dec; 29(6):353-63. PubMed ID: 25547681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elaboration of tetravalent antibody responses against dengue viruses using a subunit vaccine comprised of a single consensus dengue envelope sequence.
    Sun J; Li M; Wang Y; Hao P; Jin X
    Vaccine; 2017 Nov; 35(46):6308-6320. PubMed ID: 28987441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unique challenges faced by the clinical evaluation of dengue vaccines.
    Edelman R
    Expert Rev Vaccines; 2011 Feb; 10(2):133-6. PubMed ID: 21332260
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.